Vimarsana
Biggest News Aggregation in the World

Page 18 - Recent Operational News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recent Operational. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recent Operational Today - Breaking & Trending Today

Riot Blockchain Reports Record First Quarter 2022 Financial Results, Current Operational and Financial Highlights - Vimarsana News

Riot Blockchain Reports Record First Quarter 2022 Financial Results, Current Operational and Financial Highlights

10.05.2022 - Riot Reports a Record $79.8 Million in Total Revenue and 1,405 BTC Produced in Q1 2022CASTLE ROCK, Colo., May 10, 2022 (GLOBE NEWSWIRE) - Riot Blockchain, Inc. (NASDAQ: RIOT) (“Riot,” “Riot Blockchain” or “the Company”), an industry leader in ...

Curis Reports First Quarter 2022 Financial Results and Business Update - Vimarsana News

Curis Reports First Quarter 2022 Financial Results and Business Update

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Duos Technologies Group, Inc.: Duos Technologies Group Reports Fourth Quarter and Full Year 2021 Results - Vimarsana News

Duos Technologies Group, Inc.: Duos Technologies Group Reports Fourth Quarter and Full Year 2021 Results

JACKSONVILLE, FL / ACCESSWIRE / March 30, 2022 / Duos Technologies Group, Inc. ("Duos" or the "Company") (NASDAQ:DUOT), a provider of vision based analytical technology solutions, reported financial results

Ideal Power : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K - Vimarsana News

Ideal Power : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K

Ideal Power Reports Fourth Quarter and Full Year 2021 Financial Results AUSTIN, TX - March 17, 2022 -- Ideal Power Inc. , pioneering the development and... | March 17, 2022

Capricor Therapeutics Reports Fourth Quarter and Full Year - Vimarsana News

Capricor Therapeutics Reports Fourth Quarter and Full Year

CAP-1002 Cell Therapy Programs -Pivotal Phase 3, HOPE-3 Trial Initiation Underway- -Entered Exclusive Partnership with Nippon Shinyaku for...